June 2 (Reuters) - Orexo AB ORX.ST :
* OREXO CONTINUES TO STRENGTHEN ZUBSOLV'S PATENT PORTFOLIO
WITH
TWO NEW PATENTS
* NEW PATENTS, US PATENT NOS. 11,020,387 AND 11,020,388,
EXPIRE IN
SEPTEMBER 2032
* US PATENT AND TRADEMARK OFFICE (USPTO) HAS ISSUED ANOTHER
TWO
PATENTS RELATING TO ZUBSOLV®, OREXO'S SUBLINGUAL BUPRENORPHINE
AND NALOXONE TABLET (CII) FOR TREATMENT OF OPIOID USE DISORDER
Source text for Eikon: ID:nWkr99dm7J
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))